| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3999457 | Urologic Oncology: Seminars and Original Investigations | 2015 | 9 Pages |
Abstract
TK1 expression is significantly different in invasive UC and benign urothelium, which underlines its potential as a diagnostic marker. Although TK1 is considered to be a marker of proliferation, and TK1 RNA overexpression is associated with an aggressive UC subtype, its capability as a predictive IHC biomarker for invasive UC remains limited.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Steffen M.D., Joerg B.Sc., Katharina M.D., Ursula Kuehs, Stefan M.D., Simone M.D., Johannes M.D., Georgios M.D., Arnulf M.D., Christian M.D., Tilman M.D.,